Deliargyris EN - Search Results

1

Superior in-hospital and 30-day outcomes with abciximab versus eptifibatide: a contemporary analysis of 495 consecutive percutaneous coronary interventions.

Deliargyris EN, Upadhya B, Applegate RJ, Kutcher MA, Gandhi SK, Sane DC. Deliargyris EN, et al. J Invasive Cardiol. 2004 Nov;16(11):611-6. J Invasive Cardiol. 2004. PMID: 15550727

2

Cardiotoxicity of cancer therapy.

Tolba KA, Deliargyris EN. Tolba KA, et al. Among authors: deliargyris en. Cancer Invest. 1999;17(6):408-22. doi: 10.3109/07357909909021433. Cancer Invest. 1999. PMID: 10434952 Review. No abstract available.

3

Comparison of the CytoSorb^® 300 mL and Jafron HA380 hemoadsorption devices: an in vitro study.

Nierhaus A, Morales J, Wendt D, Scheier J, Gutzler D, Jarczak D, Born F, Hagl C, Deliargyris E, Mehta Y. Nierhaus A, et al. Minim Invasive Ther Allied Technol. 2022 Oct;31(7):1058-1065. doi: 10.1080/13645706.2022.2104617. Epub 2022 Aug 1. Minim Invasive Ther Allied Technol. 2022. PMID: 35913784

4

Mechanistic Considerations and Pharmacokinetic Implications on Concomitant Drug Administration During CytoSorb Therapy.

Scheier J, Nelson PJ, Schneider A, Colombier S, Kindgen-Milles D, Deliargyris EN, Nolin TD. Scheier J, et al. Among authors: deliargyris en. Crit Care Explor. 2022 May 9;4(5):e0688. doi: 10.1097/CCE.0000000000000688. eCollection 2022 May. Crit Care Explor. 2022. PMID: 35783552 Free PMC article. Review.

5

CytoSorb Therapy in COVID-19 (CTC) Patients Requiring Extracorporeal Membrane Oxygenation: A Multicenter, Retrospective Registry.

Song T, Hayanga J, Durham L, Garrison L, McCarthy P, Barksdale A, Smith D, Bartlett R, Jaros M, Nelson P, Molnar Z, Deliargyris E, Moazami N. Song T, et al. Front Med (Lausanne). 2021 Dec 20;8:773461. doi: 10.3389/fmed.2021.773461. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34988092 Free PMC article.

6

The Potential Role of Extracorporeal Cytokine Removal in Hemodynamic Stabilization in Hyperinflammatory Shock.

Hawchar F, Rao C, Akil A, Mehta Y, Rugg C, Scheier J, Adamson H, Deliargyris E, Molnar Z. Hawchar F, et al. Biomedicines. 2021 Jul 1;9(7):768. doi: 10.3390/biomedicines9070768. Biomedicines. 2021. PMID: 34356830 Free PMC article. Review.

7

Adjunctive therapies in the cath lab. Successful medical therapy of left main thrombosis: value of serial coronary angiography.

Deliargyris EN, Dehmer GJ, Willis PW 4th. Deliargyris EN, et al. J Invasive Cardiol. 2001 Sep;13(9):644-6. J Invasive Cardiol. 2001. PMID: 11533503

8

Aspirin resistance in cardiovascular disease: a review of prevalence, mechanisms, and clinical significance.

McKee SA, Sane DC, Deliargyris EN. McKee SA, et al. Among authors: deliargyris en. Thromb Haemost. 2002 Nov;88(5):711-5. Thromb Haemost. 2002. PMID: 12428082 Review. No abstract available.

9

Anti-platelet factor 4/heparin antibodies: an independent predictor of 30-day myocardial infarction after acute coronary ischemic syndromes.

Williams RT, Damaraju LV, Mascelli MA, Barnathan ES, Califf RM, Simoons ML, Deliargyris EN, Sane DC. Williams RT, et al. Among authors: deliargyris en. Circulation. 2003 May 13;107(18):2307-12. doi: 10.1161/01.CIR.0000066696.57519.AF. Epub 2003 Apr 21. Circulation. 2003. PMID: 12707235

10

Relation of serum levels of mast cell tryptase of left ventricular systolic function, left ventricular volume or congestive heart failure.

Upadhya B, Kontos JL, Ardeshirpour F, Pye J, Boucher WS, Theoharides TC, Dehmer GJ, Deliargyris EN. Upadhya B, et al. Among authors: deliargyris en. J Card Fail. 2004 Feb;10(1):31-5. doi: 10.1016/s1071-9164(03)00586-4. J Card Fail. 2004. PMID: 14966772

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters